Evaluation of anti-inflammatory and antinociceptive activities of Murraya exotica

Pharmaceutical Biology

Volumn 48, Issue 12, 2010, Pages 1344-1353

  Wu, Longhuo ^a,b   Li, Pei ^a   Wang, Xiao ^a   Zhuang, Zhenjing ^a   Farzaneh, Farzin ^c   Xu, Ruian ^a  

^a HUAQIAO UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anti inflammatory; Antinociceptive; Murracarpin; Murraya exotica

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; CARRAGEENAN; COUMARIN DERIVATIVE; DEXAMETHASONE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MERANZIN; MURRACARPIN; MURRAYA EXOTICA EXTRACT; OSTHOLE; PHEBALOSIN; PLANT EXTRACT; SCOPOLETIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UMBELLIFERONE; UNCLASSIFIED DRUG; XYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG SCREENING; DRUG STRUCTURE; EAR DISEASE; EAR EDEMA; ENZYME ACTIVITY; ENZYME INHIBITION; HOT PLATE TEST; INFRARED SPECTROMETRY; KNEE OSTEOARTHRITIS; MALE; MASS SPECTROMETRY; MOUSE; MURRAYA; MURRAYA EXOTICA; NONHUMAN; PAIN; PAW EDEMA; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; WRITHING TEST;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHINA; COUMARINS; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; MURRAYA; OSTEOARTHRITIS; PAIN; PLANT EXTRACTS; PLANT LEAVES; RATS;

MURRAYA EXOTICA; RATTUS;

EID: 78649339607     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880201003793723     Document Type: Article

References (45)

1. Abbott FV, Melzack R (1982): Brainstem lesions dissociated neural mechanisms of morphine analgesia in diferent kinds of pain. Brain Res 251: 149-155.
2. Abbott F V, Franklin KBJ (1986): Noncompetitive antagonism of morphine analgesia by diazepan in the formalin test. Pharmacol Biochem Behav 24: 319-321.
3. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986): Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516-518.
4. Bulut M, Erk C (1996): Improved synthesis of some hydroxycoumarins. Dyes and Pigments 30: 99-104.
5. Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ (1985): Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 17: 197-204.
6. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP (1996): Chondroprotective efect of intraar-ticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: Suppression of collagenase-1 expression. Arthritis Rheum 39: 1535-1544.
7. Chen Q (1993): Pharmacological Research Methods in Traditional Chinese Medicine. Beijing, People's Medical Publishing House, p. 305.
8. Chen YF, Tsai HY, Wu TS (1995): Anti-infammatory and analgesic activities from roots of Angelica pubescens. Planta Med 61: 2-8.
9. China Pharmacopoeia Committee (2005): Pharmacopoeia of the People's Republic of China. Beijing, Chemical Industry Press, p. 9.
10. Chopra RN, Nayar SL, Chopra IC (1956): Glossary of Indian Medicinal Plant. New Delhi, Council of Scientifc and Industrial Research, p. 171.
11. Collier HOJ, Dinneen LC, Johnson CA, Schneider C (1968): Te abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 32: 295-310.
12. Del Carlo M Jr, Loeser RF (2002): Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 46: 394-403.
13. Derart R, Jouaney S, Delevalcee F, Falhout M (1980): Release of pros-taglandins E and F in algogenic reaction and its inhibition. Eur J Pharmacol 51: 17-24.
14. Dhara AK, Suba V, Sen T, Pal S, Nagchaudhuri AK (2000): Preliminary studies on the anti-infammatory and analgesic activity of the methanolic fraction of the root extract of Tragia involucrate. J Ethnopharmacol 72: 265-268.
15. Di RM, Sorrentino L (1968): Te mechanism of the infammatory efect of carrageenan. Eur J Pharmacol 4: 340-342.
16. Di RM, Giroud JP,Willoughby DA (1971): Studies of the mediators of the acute infammatory response induced in rats in diferent sites by carrageenan and turpentine. J Pathol 104: 15-29.
17. Di RM (1972): Biological properties of carrageenan. J Pharm Pharmacol 24: 89-102.
18. Eddy NB, Leimback D (1953): Synthetic analgesics. II. Dithienylbutenyl-and dithienylbutylamines. J Pharmacol Exp Ter 107: 385-393.
19. EI-Sakhawy FS, EI-Tantawy ME, Ross SA, and EI-Sohly MA (1998): Composition and antimicrobial activity of the essential oil of Murraya exotica L. Flavour Frag J 13: 59-62.
20. He H, Dai D, Dai Y (2006): CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-κB in rats. Acta Pharmacol Sin 27: 1213-1221.
21. Ito C, Furukawa H (1987): Constituents of Murraya exotica L. structure elucidation of new coumarins. Chem Pharm Bull 35: 4277-4285.
22. Kim EK, Kwon KB, Shin BC, Seo EA, Lee YR, Kim JS, Park JW, Park BH, Ryu DG (2005): Scopoletin induces apoptosis in human promy-eloleukemic cells, accompanied by activations of nuclear factor κB and caspase-3. Life Sci 77: 824-836.
23. Lily EM (1980): Medicinal Plants of East and Southeast Asia. Cambridge, MA, MIT Press, p. 367.
24. Lu B, Wu X, Tie X, Zhang Y, Zhang Ying (2005): Toxicology and safety of anti-oxidant of bamboo leaves. Part 1: Acute and subchronic toxicity studies on anti-oxidant of bamboo leaves. Food Chem Toxicol 43: 783-792.
25. Manuele MG, Ferraro G, Barreiro Arcos ML, Lopez P, Cremaschi G, Anesini C (2006): Comparative immunomodulatory efect of scopoletin on tumoral and normal lymphocytes. Life Sci 79: 2043-2048.
26. Nakamura H, Shimoda A, Ishii K, Kadokawa T (1986): Central and peripheral analgesic action of non-acidic non-steroidal anti-infammatory drugs in mice and rats. Arch Int Pharmacody Ter 282: 16-25.
27. National Traditional Chinese Medicines Compilation (1996): Te National Traditional Chinese Medicines Compilation (Second edition). Beijing, People's Medical Publishing, p. 19.
28. Navarro DF, Souza MM, Neto RA, Golin V, Niero R, Yunes RA, Monache FD, Filho VC (2002): Phytochemical analysis and analgesic properties of Curcuma zedoaria grown in Brazil. Phytomedicine 9: 427-432.
29. Nuki G (1999): Role of mechanical factors in the aetiology, patho-genesis and progression of osteoarthritis, in: Reginster JY, Pelletier JP, Martel-Pelletier J, Henrotin Y, eds., Osteoarthritis: Clinical and Experimental Aspects. Berlin, Springer, p. 101-114.
30. Paulino N, Dantas AP, Bankova V, Longhi DT, Scremin A, Decastro SL, Calixto JB (2003): Bulgarian propolis induces analgesics and anti-infammatory efects in mice and inhibits in-vitro contraction of airway smooth muscle. J Pharmacol Sci 93: 307-313.
31. Pelletier JP, Martel-Pelletier J, Howell DS (2000): Etiopathogenesis of osteoarthritis, in: Koopman WJ, editor. Arthritis & Allied Conditions: A Textbook of Rheumatology. fourteenth edition. Baltimore, Lippincott Williams & Wilkins, pp. 2195-2245.
32. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Di Battista JA, Martel-Pelletier J (1998): Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41: 1275-1286.
33. Qi J, Li Y, Zhang H, Cheng Y, Sun Y, Cao J, Zhao Y, Wang F (2009): A novel conjugate of low-molecular-weight heparin and Cu, Zn-superoxide dismutase: Study on its mechanism in preventing brain reperfusion injury after ischemia in gerbils. Brain Res 1260: 76-78.
34. Rahman AU, Shabbir M, Sultani SZ, Jabbar A, Choudhary MI (1997): Cinnatates and coumarins from the leaves of Murraya paniculata. Phytochemistry 44: 683-685.
35. Ramesh B, Pugalendi KV (2005): Antihyperlipidemic and antidiabetic efects of umbelliferone in streptozotocin diabetic rats. Yale J Biol Med 78: 187-194.
36. Ramesh B, Pugalendi KV (2006): Antioxidant role of umbelliferone in STZ-diabetic rats. Life Sci 79: 306-310.
37. Regan EA, Bowler RP, Crapo JD (2008): Joint fuid antioxidants are decreased in osteoarthritic joints compared to joints with mac-roscopically intact cartilage and subacute injury. Osteoarthritis Cartilage 16: 515-521.
38. Rogart JN, Barrach HJ, Chichester CO (1999): Articular collagen degradation in the Hulth-Telhag model of osteoarthritis. Osteoarthr Cartil 7: 539-547.
39. Rout PK, Rao YR, Sree A, Naik SN (2007): Composition of essential oil, concrete, absolute, wax and headspace volatiles of Murraya paniculata (L.) Jack fowers. Flavour Fragr J 22: 352-357.
40. Saied S (2005): Studies in the chemical constituents of Murraya paniculata and Ipomoea hederacea. Ph.D. Tesis, University of Karachi.
41. Van de Loo AAJ, van den Berg WB (1990): Efects of murine recom-binant IL-1 on synovial joints in mice: Measurement of patellar cartilage metabolism and joint infammation. Ann Rheum Dis 49: 238-245.
42. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB (1995): Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: Efect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum 38: 164-172.
43. Vinegar R, Schreiber W, Hugo R (1969): Biphasic development of car-rageenan oedema in rats. J Pharmacol Exp Ter 166: 96-103.
44. Winter CA, Risley EA, Nuss GW (1962): Carrageenan-induced edema in hind paw of the rat as an assay for anti-infammatory drug. Pro Soc Exp Biol Med 111: 544-547.
45. Wu T-S, Liou M-J, Kuoh C-S (1989): Coumarins of the fowers of Murraya paniculata. Phytochemistry 28: 293-294.